Daiichi Sankyo Call for Pre-Proposals: Sponsored Research Program Due September 30, 2024

Summary from Daiichi Sankyo: We highly value partnerships with academic institutions to explore new therapeutic possibilities through the testing of hypotheses, fostering an environment of scientific innovation. By cultivating sustainable relationships founded on open and fair alliance management, we prioritize trust and mutual respect as the pillars for successful collaborations. Our ultimate objective is to jointly create exceptional value for patients by leveraging each other's expertise and strengths to their fullest potential.

Please find detailed information attached. The areas highlighted on Page 2 are being heavily prioritized by Daiichi Sankyo. There should be NO confidential information disclosed in the pre-proposals.

Amount of funding: Up to $500,000 USD for one year including overhead/indirect costs

Note: Submissions for the pre-proposal stage do not need to go through RMG or OSR for institutional approval; however, IRDH will be working with OTL/ICO to review the pre-proposal before it is submitted to Daiichyo Sankyo; please follow instructions below.

Eligibility: Stanford faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver). CE applicants must obtain an approved CE faculty PI waiver BEFORE the pre-proposal deadline. Instructions for CE faculty PI waiver requests: Submit the required, completed CE faculty PI waiver template and attachments directly to Kathleen Thompson at klt@stanford.edu by end of day on September 24, 2024. Please do not contact your RPM/RMG or CGO/OSR regarding waivers for this program.
 

Areas of Interest:

• Oncology

• Central nervous system

• Fibrosis, cardiovascular, and ophthalmic disease

• Cell and gene therapy

• Modality based technologies

• Drug discovery technologies

• Disease indications better detailed here: https://www.daiichisankyo.com/rd/open_innovation/our_interests/

Timeline:

September 24, 2024 – CE faculty PI waiver requests due (if applicable)

September 30, 2024 – Pre-proposal submission deadline to Stanford Medicine - Industry Relations (SM-IR) team

(see instructions below)

October 8, 2024 – OTL/ICO review deadline

October 11, 2024 – Submission of completed pre-proposals to Daiichi Sankyo by SM-IR

Deadlines and instructions for full proposal submission will be announced at a later time to selected faculty.

Submission Instructions for Pre-proposals:

There is no set template for this submission, though we’ve provided a sample document for your consideration. Otherwise, a plain Word document with the proposal details is sufficient (best to limit to 2 pages). Email the complete pre-proposal to Nicole Kay at nkay@stanford.edu before September 30, 2024. The Industry Relations team will review the submissions with the Office of Technology Licensing (OTL)/Industry Contracting Office (ICO) and then formally submit all pre-proposals to Daiichi Sankyo on behalf of Stanford.

There should be NO confidential information disclosed in the pre-proposals.

Institutional representative: you do not need to submit your pre-proposals through RMG or OSR for institutional approval; you may submit your pre-proposal directly to Nicole Kay per the instructions above. If invited to submit a full proposal, please initiate your Proposal Intake Form (PIF) at your earliest convenience. Final proposal submission will require institutional approval prior to submission. Any CE faculty PI waiver requests should be submitted directly to Kathleen Thompson per the instructions above before the pre-proposal is submitted.

Questions? Please contact John Lugo at johnlugo@stanford.edu and/or Nicole Kay at nkay@stanford.edu.

Stanford Resources

Funding Information for the Stanford community Limited submission programs, NIH resources, DoD CDMRP, internal funding opportunities, searchable funding databases.

For full proposal stage only:

Institutional representatives and Internal Proposal Deadline Policy School of Medicine PIs: RPM Department Assignments and SoM internal proposal deadline policy A Proposal Intake Form (PIF) in SeRA is required for all sponsored project proposal submissions in the School of Medicine (except for fellowships, clinical trials, and Internal Seed Funding NOT from sponsored projects). PIs in all Other Schools: Office of Sponsored Research (OSR) Contract and Grant Officer Pre-Award & Post-award department assignments